Laboratory Automation Solutions Designed to Boost Productivity Showcased at SLAS 2018

Laboratory Automation Solutions Designed to Boost Productivity Showcased at SLAS 2018 SAN DIEGO, Feb. 6, 2018 /PRNewswire/ — SLAS 2018 – Thermo Fisher Scientific, the world leader in serving science, today announced new laboratory automation technologies designed to streamline workflows, optimize productivity, and speed time to results. The new solutions are on display this week... Read more

Congenica Appoints New CEO to Drive Global Expansion of Clinical Genomics Business

Cambridge, United Kingdom – 25 January 2018 –Congenica, a global provider of clinical genomics interpretation software, today announced the appointment of its new Chief Executive Officer David Atkins, Ph.D. Based at the Company’s headquarters in Cambridge, UK, Dr Atkins also joins Congenica’s Board of Directors. Dr Atkins has over 25 years’ experience as a global... Read more

QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing

New system launch planned for second half of 2018 with two CE-IVD molecular diagnostics, U.S. launch planned for 2019 and broad pipeline in development Germantown, Maryland, and Hilden, Germany, January 31, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today it has entered into an agreement to acquire STAT-Dx, a privately-held company developing... Read more

BGI Increases Long-Read Sequencing Capacity with Purchase of 10 PacBio Sequel Systems

MENLO PARK, California and SHENZHEN, China, Jan. 25, 2018 (GLOBE NEWSWIRE) — BGI, one of the world’s largest genomics organizations, and Pacific Biosciences of California, Inc. (Nasdaq: PACB), the leader in long-read sequencing, today announced an agreement by BGI Genomics to purchase an additional 10 Sequel® Systems. This will significantly expand the capacity for Single Molecule, Real-Time... Read more

QIAGEN introduces GeneReader NGS System

Austin, Texas, and Hilden, Germany, November 4, 2015 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the start of commercialization activities for its GeneReader NGS System, the first complete Sample to Insight next-generation sequencing (NGS) solution designed for any laboratory to deliver actionable results. With the introduction of the GeneReader NGS System*,... Read more

Beckman Coulter Life Sciences Launches New Family of FFPE Reagent Kits

Single Chemistry System Extracts Total Nucleic Acid, DNA and/or RNA From Single FFPE Tissue Sample INDIANAPOLIS, IND. (January 18, 2018) – Today, Beckman Coulter Life Sciences launched a family of FormaPure reagent kits for extracting nucleic acid from often challenging formalin-fixed, paraffin-embedded (FFPE) tissues. FormaPure reagent kits represent a single chemistry system designed and optimized for... Read more

PRECIPIO APPOINTS NEW SALES VP TO MANAGE DIAGNOSTICS SALES EXPANSION

SALES GROWTH ACCELERATION PLAN TO TRIPLE SIZE OF ONCOLOGIST/HOSPITAL SALES TEAM IN 2018 NEW HAVEN, Conn., Jan. 16, 2018 (GLOBE NEWSWIRE) — Specialty diagnostics firm Precipio, Inc. (NASDAQ:PRPO) has appointed Douglas Sites to the new position of Vice President of Sales where he will be responsible for executing Precipio’s Pathology Services sales plan, targeting oncologists... Read more

Vertebrate Genomes Project Will Create a Digital Genome Ark; DNAnexus to Support Reference Assemblies of All Vertebrate Species

Global research consortium leverages DNAnexus cloud-based platform to scale analyses for the world’s animal kingdom January 16, 2018 08:00 AM Eastern Standard Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus, the global leader in genome informatics and data management, today announced that the Genome10K’s (G10K) Vertebrate Genomes Project (VGP) will utilize the DNAnexus Platform in assembling and analyzing... Read more

Luna DNA Announces Dawn Barry, former Illumina VP, as President

As President, Dawn Barry will be responsible for leading operations, communicating and implementing company mission, and guiding overall strategy, direction, and growth at Luna DNA. SAN DIEGO, Jan. 15, 2018 /PRNewswire/ — Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced today Dawn Barry as president. In... Read more

10x Genomics Accelerates Plant and Animal Research with Supernova 2.0

–Optimized sample preparation protocols and software algorithms enable high-quality, cost-effective de novo assembly for agrigenomics and other non-human applications at scale.– PLEASANTON, CA.—January 15, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today launched a new version of their de novo assembly solution to provide the fastest most cost-effective solution for creating high-quality de novo assemblies at scale for... Read more